[EN] CINNOLINES AS INHIBITORS OF HPK 1<br/>[FR] CINNOLINES UTILISÉES COMME INHIBITEURS DE HPK 1
申请人:NANJING ZHENGXIANG PHARMACEUTICALS CO LTD
公开号:WO2021004535A1
公开(公告)日:2021-01-14
Compounds of Formula (I) or (Ia), pharmaceutically acceptable salts, stereoisomers, tautomers, solvates or prodrugs, and their use as HPK1 inhibitors are described herein, and also described are methods for preparing the compounds, and methods of treating HPK1-dependent diseases or disorders, such as cancer.
本文描述了化学式(I)或(Ia)的化合物,药用盐,立体异构体,互变异构体,溶剂合物或前药,以及它们作为HPK1抑制剂的用途,还描述了制备这些化合物的方法,以及治疗HPK1依赖性疾病或疾病的方法,如癌症。